BIOL
417
Translational Immunology: From Bench to Bedside
Spring 2022
Division III
This is not the current course catalog
Class Details
Recent advances in the field of immunology have led to the development of new approaches to prevent and treat diseases that affect millions of people worldwide. Drugs that modulate the body’s natural immune response have become powerful tools in treating major diseases–infection, autoimmunity and cancer. This course will use readings from the primary literature to explore central themes involved in translating basic research to new clinical and therapeutic approaches. Topics will include vaccine development, autoimmunity and cancer immunotherapy.
The Class:
Format: seminar
Limit: 12
Expected: 12
Class#: 3068
Grading: no pass/fail option, no fifth course option
Limit: 12
Expected: 12
Class#: 3068
Grading: no pass/fail option, no fifth course option
Requirements/Evaluation:
Class participation and 4 essays
Prerequisites:
BIOL 202; open to juniors and seniors
Enrollment Preferences:
senior biology majors who have not taken a 400-level course; then juniors
Unit Notes:
does not satisfy the distribution requirement for the Biology major
Distributions:
Division III
Attributes:
PHLH Biomedical Determinants of Health
Class Grid
-
HEADERS
Column header 1
CLASSESColumn header 2DREQColumn header 3INSTRUCTORSColumn header 4TIMESColumn header 5CLASS#
-
BIOL 417 - 01 (S) SEM Translational Immunology
BIOL 417 - 01 (S) SEM Translational ImmunologyDivision IIIMWF 10:00 am - 10:50 am
Hopper3068
Megamenu Social